The stent, called the Evolution Duodenal Controlled-Release Stent, will be available to use to combat gastric outlet obstruction as a result of advanced GI cancers. A European study found that 21 of 23 patients had “significant improvement” with the stent.
Related Articles about FDA Device Approvals:
GE’s New MRI Machine Gets FDA Approval
FDA Forms Expert Panel to Speed up Device Approval
FDA Continuing Work to Improve Sound Development of Medical Products
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
